New phase 3 data support the use of the levonorgestrel 52 mg intrauterine device (IUD) in nulliparous women with obesity and heavy menstrual bleeding. The findings, presented at the 2022 annual ...

The primary indication for cesarean section in nulliparous women continues to be clinical diagnoses that fall under the rubric of dystocia. These diagnoses account for approximately two-thirds of all ...

BALTIMORE -- The levonorgestrel 52-mg intrauterine device (IUD; Mirena) decreased blood loss by more than 90% for women with heavy menstrual bleeding, an open-label phase III trial showed. Among 89 ...

Please provide your email address to receive an email when new articles are posted on . Elective labor induction rose by 42% after publication of the ARRIVE trial of induction outcomes. No significant ...

The management of labour in nulliparous women presents unique challenges, as these women have no previous birth experience to guide prognostication and intervention. Current evidence highlights the ...

Please provide your email address to receive an email when new articles are posted on . Newly-designed hormone-free IUD was successful for preventing pregnancy at 3 years. Placement success was high ...

Approximately 10% to 40% of nulliparous women in Sweden reported having urinary incontinence. All aspects of urinary incontinence have been reported in nulliparous women, with increasing prevalence ...

IUD device LARC is safe and effective in nulliparous adolescents and should be considered as a viable alternative to oral contraception. SAN ANTONIO – Long-acting reversible contraception (LARC) ...

Healthcare Reform and Women’s Health Preventive Services: What is Now Cost-Free to the Patient? Miss C, a nulliparous 23-year-old woman, arrives as a new patient for an annual exam. She is also ...

It is uncertain whether women who deliver by cesarean section have an increased risk of urinary incontinence as compared with nulliparous women and whether women who deliver vaginally have an even ...